| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,948,284 |
|
|
Indirect Shares
|
60,990,264 |
|
|
| Direct
Value |
$182,506,866 |
|
|
|
Indirect Value
|
$155,055,576 |
|
|
| Total
Shares |
88,938,548 |
|
|
| Total
Value |
$337,562,442 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
95
|
|
Stock
price went up :
|
14
|
1
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.6%
|
-5,816.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-19 |
1,566,956 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-01-23 |
7,594 |
2024-01-23 |
6,955,191 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2023-08-23 |
30,707,722 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2024-01-23 |
4 |
A |
$0.00 |
$0 |
I/I |
1,156,069 |
6,949,694 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-12-19 |
4 |
S |
$0.21 |
$7,430 |
I/I |
(36,000) |
1,566,956 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-12-08 |
4 |
S |
$0.24 |
$8,320 |
I/I |
(35,000) |
1,602,956 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-10-06 |
4 |
S |
$0.30 |
$11,448 |
I/I |
(37,931) |
872,956 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-10-05 |
4 |
S |
$0.30 |
$3,216 |
I/I |
(10,670) |
910,887 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-10-04 |
4 |
S |
$0.31 |
$12,867 |
I/I |
(41,399) |
921,557 |
0 |
% |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-08-23 |
4 |
B |
$1.71 |
$149,240 |
I/I |
87,500 |
30,707,722 |
0.01 |
- |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-08-22 |
4 |
B |
$1.67 |
$13,859 |
I/I |
8,307 |
30,620,222 |
0.01 |
- |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-08-21 |
4 |
B |
$1.64 |
$53,411 |
I/I |
32,556 |
30,611,915 |
0.01 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-08-15 |
4 |
B |
$0.65 |
$497,250 |
I/I |
765,000 |
1,637,956 |
0.01 |
% |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-08-03 |
4 |
A |
$1.62 |
$16,183,000 |
I/I |
9,989,506 |
30,579,359 |
0 |
- |
|
| AWH |
Aspira Womens Health Inc |
|
• • • |
2023-07-24 |
4 |
B |
$2.75 |
$499,950 |
I/I |
181,800 |
1,883,656 |
0.01 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2023-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
75,949 |
75,949 |
0 |
- |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-05-31 |
4 |
B |
$1.35 |
$20,006 |
I/I |
14,792 |
20,589,853 |
0.01 |
- |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-05-30 |
4 |
B |
$1.36 |
$16,150 |
I/I |
11,849 |
20,575,061 |
0.01 |
- |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-05-25 |
4 |
B |
$1.36 |
$71,280 |
I/I |
52,508 |
20,563,212 |
0.01 |
- |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-05-24 |
4 |
B |
$1.25 |
$43,980 |
I/I |
35,308 |
20,510,704 |
0.01 |
- |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-05-23 |
4 |
B |
$1.15 |
$65,066 |
I/I |
56,782 |
20,475,396 |
0.01 |
- |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-05-22 |
4 |
B |
$1.11 |
$32,529 |
I/I |
29,425 |
20,418,614 |
0.01 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-05-05 |
4 |
B |
$2.98 |
$999,999 |
I/I |
335,570 |
962,956 |
0.01 |
% |
|
| BDSX |
Biodesix Inc |
Director |
– • • |
2023-01-31 |
4 |
B |
$2.41 |
$24,100 |
I/I |
10,000 |
20,389,189 |
2.17 |
- |
|
| BDSX |
Biodesix Inc |
Director |
– • • |
2023-01-27 |
4 |
B |
$2.51 |
$125,430 |
I/I |
50,000 |
20,379,189 |
2.25 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-20 |
4 |
S |
$1.78 |
$1,082 |
I/I |
(608) |
627,386 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-19 |
4 |
S |
$1.76 |
$8,976 |
I/I |
(5,100) |
627,994 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-16 |
4 |
S |
$1.82 |
$12,740 |
I/I |
(7,000) |
633,094 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
